Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection

SIV 感染时外周组织和淋巴组织的树突状细胞动态

基本信息

项目摘要

DESCRIPTION (provided by applicant): Dendritic cells (DC) and monocytes/macrophages (Mo/M¿) are innate immune cells that play a critical role in the host response to viral infection b mediating antiviral activity and inducing adaptive immune responses. However, in human immunodeficiency virus (HIV) infection of humans this relationship between DC, Mo/M¿ and virus control is not clear, as generalized immune activation that is a central feature of progression to AIDS may be driven by an overactive innate immune response to infection. Hence, a central unanswered question in HIV pathogenesis is whether the DC and Mo/M¿ response to infection is desirable or detrimental. This represents a critical impediment to progress in the field, as we do not know if therapeutic strategies should be aimed at blocking or promoting innate immunity. In this proposal we will address this central question in simian immunodeficiency virus (SIV) infection of rhesus macaques, which models HIV infection of humans. We will prospectively study the DC and Mo/M¿ response in SIVmac251-infected macaques with controlled infection vs. normal or rapid progression and compare this to macaques infected with SIVmac251 and treated with antiretroviral therapy or infected with attenuated SIVmac239¿nef. With this full spectrum of outcomes of infection we will be able to put into context the relevance of the DC and Mo/M¿ response to AIDS pathogenesis. In addition, we will use a novel humanized antibody specific for one subset of DC, the plasmacytoid DC, to deplete these cells at the time of infection or during the chronic phase. This will, for the first time, allow us to directly determine the contribution of plasmacytoid DC to virs control and chronic immune activation. These hypothesis-driven studies will further define the role of DC and Mo/M¿ in HIV infection and provide direction for development of therapeutics targeting innate immunity.
描述(由申请人提供):树突状细胞(DC)和单核/巨噬细胞(Mo/M¿)是先天免疫细胞,在宿主对病毒感染的反应中发挥关键作用,介导抗病毒活性和诱导适应性免疫反应。然而,在人类免疫缺陷病毒(HIV)感染中,DC、Mo/M¿和病毒控制之间的关系尚不清楚,因为作为艾滋病进展的核心特征的全身免疫激活可能是由对感染的过度活跃的先天免疫反应驱动的。因此,艾滋病毒发病机制中一个悬而未决的核心问题是DC和Mo/M¿对感染的反应是可取的还是有害的。这是该领域进展的一个重大障碍,因为我们不知道治疗策略是否应该以阻断或促进先天免疫为目标。在本提案中,我们将解决猕猴猴免疫缺陷病毒(SIV)感染的核心问题,这是人类HIV感染的模型。我们将前瞻性地研究感染SIVmac251的猕猴在控制感染与正常或快速进展的情况下的DC和Mo/M反应,并将其与感染SIVmac251并接受抗逆转录病毒治疗或感染减毒SIVmac239的猕猴进行比较。有了这种全面的感染结果,我们将能够将DC和Mo/M¿应对艾滋病发病机制的相关性纳入背景。此外,我们将使用一种新的人源化抗体,专门针对DC的一个亚群,浆细胞样DC,在感染时或在慢性期消耗这些细胞。这将使我们第一次能够直接确定浆细胞样DC对病毒控制和慢性免疫激活的贡献。这些假设驱动的研究将进一步确定DC和Mo/M¿在HIV感染中的作用,并为开发针对先天免疫的治疗方法提供方向。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Simon M Barratt-Boyes其他文献

Enemy at the gates: dendritic cells and immunity to mucosal pathogens
城门失火:树突状细胞与对黏膜病原体的免疫
  • DOI:
    10.1038/cr.2010.94
  • 发表时间:
    2010-07-06
  • 期刊:
  • 影响因子:
    25.900
  • 作者:
    Adam C Soloff;Simon M Barratt-Boyes
  • 通讯作者:
    Simon M Barratt-Boyes

Simon M Barratt-Boyes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Simon M Barratt-Boyes', 18)}}的其他基金

Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
通过靶向溶酶体治疗 COVID-19 的宿主防御小分子开发
  • 批准号:
    10735492
  • 财政年份:
    2023
  • 资助金额:
    $ 69.33万
  • 项目类别:
Immunity to Live Mosquito Probing and Flavivirus Infection in Human Skin
人类皮肤对活蚊探测和黄病毒感染的免疫力
  • 批准号:
    9807252
  • 财政年份:
    2019
  • 资助金额:
    $ 69.33万
  • 项目类别:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
SIV 感染时外周组织和淋巴组织的树突状细胞动力学
  • 批准号:
    8473151
  • 财政年份:
    2012
  • 资助金额:
    $ 69.33万
  • 项目类别:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
SIV 感染时外周组织和淋巴组织的树突状细胞动态
  • 批准号:
    8828540
  • 财政年份:
    2012
  • 资助金额:
    $ 69.33万
  • 项目类别:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
SIV 感染时外周组织和淋巴组织的树突状细胞动力学
  • 批准号:
    8416465
  • 财政年份:
    2012
  • 资助金额:
    $ 69.33万
  • 项目类别:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
SIV 感染时外周组织和淋巴组织中的树突状细胞动力学
  • 批准号:
    7923493
  • 财政年份:
    2009
  • 资助金额:
    $ 69.33万
  • 项目类别:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
SIV 感染时外周组织和淋巴组织中的树突状细胞动力学
  • 批准号:
    7385998
  • 财政年份:
    2007
  • 资助金额:
    $ 69.33万
  • 项目类别:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
SIV 感染时外周组织和淋巴组织的树突状细胞动力学
  • 批准号:
    7782672
  • 财政年份:
    2007
  • 资助金额:
    $ 69.33万
  • 项目类别:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
SIV 感染时外周组织和淋巴组织的树突状细胞动力学
  • 批准号:
    8044793
  • 财政年份:
    2007
  • 资助金额:
    $ 69.33万
  • 项目类别:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
SIV 感染时外周组织和淋巴组织中的树突状细胞动力学
  • 批准号:
    7572945
  • 财政年份:
    2007
  • 资助金额:
    $ 69.33万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 69.33万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了